Breaking news: FDA approves EC pill without prescription

Article

The US Food and Drug Administration (FDA) has approved the Plan B One-Step levonorgestrel pill for emergency contraception (EC) without prescription for women aged 15 and older, although proof of age must be provided at the time of purchase.

 

The US Food and Drug Administration (FDA) has approved the Plan B One-Step levonorgestrel pill for emergency contraception (EC) without prescription for women aged 15 and older, although proof of age must be provided at the time of purchase.

The FDA says that its approval of Teva Women’s Health’s amended application to make the drug available over-the-counter to all women of reproductive age is independent of an April 5 federal court ruling that ECs be made available in pharmacies to women without age restriction or a prescription.

In that ruling, Judge Edward R. Korman of the US District Court for the Eastern District of New York concluded that restricting ECs for girls aged younger than 17 was not based on scientific evidence. The action effectively overruled a decision by the US Department of Health and Human Services in 2011 that restricted young girls’ access to drugs that prevent pregnancy after unprotected sexual intercourse. The FDA had 30 days to respond.

Plan B One-Step now will be labeled “not for sale to those under 15 years of age *proof of age required* not for sale where age cannot be verified.” The product will be placed in family planning and women’s health sections of retail outlets with an on-site pharmacy and will be available for purchase any time the retailer is open even if the pharmacy is not. The packaging will contain a product code that prompts a cashier to request the customer’s identification to verify age at the time of purchase and also a security tag to prevent theft.

FDA says its decision is based on actual use studies and comprehension data showing that girls and women aged 15 and older can use ECs properly without the intervention of a health care provider.

Recent Videos
Empowering women to take charge of their health | Image Credit: © piecesofi.com - © piecesofi.com - stock.adobe.com.
Supporting women through menopause with knowledge and care | Image Credit: © SHOTPRIME STUDIO - © SHOTPRIME STUDIO - stock.adobe.com.
How fezolinetant revolutionizes non-hormonal menopause therapy | Image Credit: imsociety.org
Gulf War exposures linked to early menopause in women veterans | Image Credit: linkedin.com.
Vanessa Muñiz discusses benefits of clinical hypnosis against hot flashes | Image Credit: mindbodymedicine.artsandsciences.baylor.edu
Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
Lauren Streicher, MD
© 2024 MJH Life Sciences

All rights reserved.